Bausch + Lomb issued the recall after the company received reports of toxic anterior segment syndrome, or an inflammatory ...

NEW YORK CITY, NY / ACCESS Newswire / April 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

The eye health company Bausch + Lomb announced on Monday that it is recalling several of its intraocular lenses due to safety ...

Bausch + Lomb has announced a voluntary recall of intraocular lenses on its enVista platform due to the potential for an ...

Bausch + Lomb said on Thursday it will recall some of its implantable eye lenses after receiving reports of complications, ...

Bausch + Lomb is recalling intraocular lenses (IOLs) on its enVista platform. This action was taken after the company ...

Learn more about whether Bausch + Lomb Corporation or Penumbra, Inc. is a better investment based on AAII's A+ Investor ...

Most cases of TASS can be treated with steroids within a few days, although severe cases can lead to permanent damage to the ...

Bausch + Lomb BLCO shares ended the last trading session 13.9% higher at $12.53. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...

Bausch+Lomb’s Biotrue multi-purpose lens care solution secured a top three ranking in the contact lens category for the ...

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.